Injections of hyaluronic acid for the treatment of osteoarthritis (Ostenil, Synvisc) are not funded, in view of NICE guidance on the lack of cost-effectiveness.
They are funded for treatment of patients with pain from early chondral damage within the knee. An internal prior approval process is in place within UHCW.
(Visited 7,303 times, 708 visits today)
Leave feedback
You must be logged in to post a comment.